Boston Scientific Corp
(FRA:BSX)
€
37.66
-1.57 (-4%)
Market Cap: 53.69 Bil
Enterprise Value: 64.29 Bil
PE Ratio: 17.45
PB Ratio: 2.50
GF Score: 80/100 
Boston Scientific Corp at Canaccord Genuity Growth Conference Transcript
Aug 08, 2019 / 02:00PM GMT
Release Date Price:
€38.28
(+3.94%)
Jason Richard Mills
Canaccord Genuity Corp., Research Division - MD of Research & Analyst
Hi, good morning. Maybe get started as people file in so that we can get in as many questions here with Boston Scientific. Very happy to have Boston Scientific, a local company but certainly a global company, at the Canaccord conference. Again, I'm Jason Mills, senior medical devices analyst. Very happy to have the Head of Investor Relations, Susie Lisa; and also Lauren as well with her to talk about the business. Thank you very much for coming.
Susan Vissers Lisa
Boston Scientific Corporation - VP of IR
Thanks for having us. Yes.
Jason Richard Mills
Canaccord Genuity Corp., Research Division - MD of Research & Analyst
And hopefully, this is a productive meeting for you guys as well as you tell your story.
Questions & Answers
Jason Richard Mills
Canaccord Genuity Corp., Research Division - MD of Research & Analyst
Recent news, let's just start there and
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers